Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation

Volume: 20 Number: 2 February 2, 2016
EN TR

Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation

Abstract

ABSTRACT

 

The aim of the present study was to develop and validate of voriconazole by using High-Performance Liquid Chromatography (HPLC). As mobile phase, mixture of acetonitrile and ultrapure water (50:50) (v/v) was used. The column was a C18 column (5µm,150x4,6mm). The eluent was monitored with UV detection at 256 nm at flow rate of 1 mL/min. The method was validated partially with respect to system suitability, linearity, limit of detection (LOD) and quantitation (LOQ), precision, accuracy and specificity, selectivity and stability. Obtained results were shown, the analytical method has good linearity, accuracy, precision, selectivity and stability. Analytical method development results indicated that the LOD was 0.02176 µg/mL; LOQ was 0.06528 µg/mL assay exhibited a linear range of 1- 30 mg/L.

Keywords

References

  1. REFERENCES
  2. Zhoua L, Glickmanb RD, Chenb N, Sponsel WE, Graybill JR, Lam KW. Determination of voriconazole in aqueous humor by liquid chromatography–electrospray ionization-mass spectrometry. Journal of Chromatography B 2002; 776: 213–220.
  3. Babu GS, Raju AI. UV-Spectrophotometric Determination of Voriconazole in Bulk and Its Formulation. Center of Biotechnology, Department of Chemical Engineering, Andhra University 2007;19: 1625-1627.
  4. Office of Pharmaceutical Science. The Biopharmaceutics Classification System (BCS) Guidance, , http://www.fda.gov/cder/OPS/BCS_guidance.htm
  5. Yang W, Wiederhold NP, Williams RO, 3rd. Drug delivery strategies for improved azole antifungal action. Expert Opin Drug Deliv 2008; 5: 1199–1216.
  6. Zhang AY, Camp WL, and Elewski BE. Advances in Topical and Systemic Antifungals. Dermatologic Clinics 2007; 25: 165-183.
  7. Kumar R, Sinha VR. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids and Surfaces B: Biointerfaces 2014; 117: 82–88.
  8. Moemen D, Bedir T, Awad EA, Ellayeh A. Fungal keratitis: Rapid diagnosis using methylene blue stain. Egyptian Journal of Basic and Applied Sciences 2015; doi:10.1016/j.ejbas.2015.08.001

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Emre Şefik Çağlar This is me

Vildan Yozgatlı This is me

Publication Date

February 2, 2016

Submission Date

November 18, 2015

Acceptance Date

-

Published in Issue

Year 2016 Volume: 20 Number: 2

APA
Üstündağ Okur, N., Çağlar, E. Ş., & Yozgatlı, V. (2016). Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation. Marmara Pharmaceutical Journal, 20(2), 79-85. https://doi.org/10.12991/mpj.20162076793
AMA
1.Üstündağ Okur N, Çağlar EŞ, Yozgatlı V. Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation. J Res Pharm. 2016;20(2):79-85. doi:10.12991/mpj.20162076793
Chicago
Üstündağ Okur, Neslihan, Emre Şefik Çağlar, and Vildan Yozgatlı. 2016. “Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and Its Pharmaceutical Formulation”. Marmara Pharmaceutical Journal 20 (2): 79-85. https://doi.org/10.12991/mpj.20162076793.
EndNote
Üstündağ Okur N, Çağlar EŞ, Yozgatlı V (February 1, 2016) Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation. Marmara Pharmaceutical Journal 20 2 79–85.
IEEE
[1]N. Üstündağ Okur, E. Ş. Çağlar, and V. Yozgatlı, “Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation”, J Res Pharm, vol. 20, no. 2, pp. 79–85, Feb. 2016, doi: 10.12991/mpj.20162076793.
ISNAD
Üstündağ Okur, Neslihan - Çağlar, Emre Şefik - Yozgatlı, Vildan. “Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and Its Pharmaceutical Formulation”. Marmara Pharmaceutical Journal 20/2 (February 1, 2016): 79-85. https://doi.org/10.12991/mpj.20162076793.
JAMA
1.Üstündağ Okur N, Çağlar EŞ, Yozgatlı V. Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation. J Res Pharm. 2016;20:79–85.
MLA
Üstündağ Okur, Neslihan, et al. “Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and Its Pharmaceutical Formulation”. Marmara Pharmaceutical Journal, vol. 20, no. 2, Feb. 2016, pp. 79-85, doi:10.12991/mpj.20162076793.
Vancouver
1.Neslihan Üstündağ Okur, Emre Şefik Çağlar, Vildan Yozgatlı. Development and Validation of an Hplc Method for Voriconazole Active Substance in Bulk and its Pharmaceutical Formulation. J Res Pharm. 2016 Feb. 1;20(2):79-85. doi:10.12991/mpj.20162076793

.